C4 and Roche Expand DAC Cancer Drug Collaboration
WATERTOWN, Mass., April 09, 2026 C4 Therapeutics, Inc. has announced a major expansion of its long-term collaboration with Roche,...
Antibody Drug Conjugates
Advertisement
Gilead Acquires Tubulis to Boost Oncology Pipeline
FOSTER CITY, California, United States & MUNICH, Germany, April 7, 2026 Gilead Sciences, Inc. announced a definitive agreement to...
Voro Therapeutics Partners with Daiichi Sankyo on ADCs
SAN DIEGO, CA, March 17, 2026 Voro Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its...
Veraxa Biotech Advances SPAC Merger Plans
ZURICH, Switzerland – February 27, 2026 Veraxa Biotech AG announced that its shareholders have approved the previously disclosed business...
Immunome Issues Inducement Equity Grants
BOTHELL, Wash., Feb. 6, 2026 — Immunome, Inc., a clinical-stage biotechnology company developing targeted oncology therapeutics, announced that its...
Advertisements
EMA Validates ENHERTU Combo for First-Line HER2 Breast Cancer
TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...
DISCO–Amgen License Deal Advances Surfaceome Cancer Therapies
COLOGNE, Germany – January 7, 2026 — DISCO Pharmaceuticals has entered into an exclusive global license agreement with Amgen...
Advertisement
